Victory Capital Management Inc Cure Vac N.V. Transaction History

Victory Capital Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$49.26 - $74.5 $1.18 Million - $1.79 Million	-24,044 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$56.91 - $127.53 $36,479 - $81,746	-641 Reduced 2.6%	24,044 $1.77 Million
Q1 2021 May 04, 2021	BUY	$79.79 - $126.29 $1.97 Million - $3.12 Million	24,685 New	24,685 $2.26 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.